Insider Trading March 30, 2026

Horace Mann CMO Makes Modest Stock Purchase as Company Posts Strong Q4 Results

Steven R. Chauby acquires 180 shares amid attractive valuation metrics and a temporary accounting leadership shift

By Hana Yamamoto HMN
Horace Mann CMO Makes Modest Stock Purchase as Company Posts Strong Q4 Results
HMN

Horace Mann Educators Corp Chief Marketing Officer Steven R. Chauby bought 180 shares on March 26, 2026, spending $7,632 at $42.40 per share. The purchase leaves Chauby with 4,643.023 shares directly and 500 shares indirectly through a domestic partner. The $1.7 billion insurance company reported Q4 2025 results that exceeded analysts' expectations and has announced a temporary change in its accounting leadership while maintaining a 3.4% dividend yield and a 16-year consecutive dividend growth record, according to InvestingPro data.

Key Points

  • CMO Steven R. Chauby purchased 180 shares on March 26, 2026, paying $42.40 per share for a total of $7,632; he now directly owns 4,643.023 shares and indirectly owns 500 shares through a domestic partner.
  • Horace Mann reported Q4 2025 results with EPS of $1.21 versus a $1.17 estimate and revenue of $434.8 million versus a $314.05 million projection; the company is described as a $1.7 billion insurance firm offering a 3.4% dividend yield and 16 consecutive years of dividend increases.
  • Valuation metrics cited include a P/E of 10.87 and a PEG of 0.18, and InvestingPro places Horace Mann on a Most Undervalued list relative to Fair Value; an interim accounting officer has been named while the Chief Accounting Officer is on maternity leave.

Horace Mann Educators Corp (NYSE:HMN) Chief Marketing Officer Steven R. Chauby completed a purchase of company common stock on March 26, 2026, acquiring 180 shares at $42.40 per share for a total outlay of $7,632.

Following the transaction, Chauby's direct holdings in Horace Mann total 4,643.023 shares. He also maintains an indirect stake of 500 shares through a domestic partner, as reported.

Market valuation metrics cited alongside the filing show Horace Mann trading at a price-to-earnings ratio of 10.87 and a price/earnings-to-growth ratio of 0.18. InvestingPro analysis referenced in the filing places the company on a Most Undervalued list relative to its Fair Value, indicating that, by that assessment, the stock appears inexpensive on those measures.

Horace Mann, described in the filing as a $1.7 billion insurance company, offers a dividend yield of 3.4% and, according to InvestingPro Tips, has increased its dividend for 16 consecutive years. The filing notes that interested investors can obtain a Pro Research Report for HMN and more than 1,400 U.S. equities for deeper analysis.


Separately, Horace Mann reported fourth-quarter 2025 financial results that surpassed consensus expectations. The company posted earnings per share of $1.21, above the $1.17 forecast. Revenue for the quarter was reported at $434.8 million, materially higher than the projected $314.05 million.

The company also disclosed a temporary change in its accounting leadership. Maureen Temchuk, Vice President, Controller, and Chief Accounting Officer, will begin a maternity leave of absence. In her absence, Ryan Greenier, the Executive Vice President and Chief Financial Officer, will assume the responsibilities of Interim Chief Accounting Officer. The filing highlights Greenier's tenure in several roles within the company, including Deputy Chief Financial Officer and Chief Investment Officer.

These developments combine a modest insider purchase with notable company-level updates: an earnings beat and a brief reallocation of accounting duties at the senior level. The disclosed valuation metrics and dividend history provide additional context for investors evaluating Horace Mann's position within the insurance sector.

Risks

  • Temporary change in accounting leadership while the Chief Accounting Officer is on maternity leave introduces an operational and reporting transition that investors should monitor, particularly in the insurance and financial reporting functions.
  • Although Q4 2025 results beat estimates, past quarter outperformance does not guarantee future earnings trends or revenue performance for the insurance sector.
  • Valuation assessments noting the stock as undervalued are based on InvestingPro analysis; such metrics reflect one view of fair value and may not capture all company-specific or sector risks.

More from Insider Trading

GlobalFoundries’ CLO Disposes of $22,995 in Stock as Company Faces Legal and Capital Moves Mar 30, 2026 Lemonade Director Increases Stake with $485k in Stock Purchases Mar 30, 2026 Neuronetics Insider Adds $675,000 in Shares as Company Reports Mixed Q4 Results Mar 30, 2026 IperionX President Purchases $262,552 in ADS as Coverage Begins and Production Ramps Mar 30, 2026 LightPath CEO Makes Small Personal Purchase as Company Posts Revenue Beat but EPS Misses Mar 30, 2026